BATF3 and colitis: To elucidate the impact that metabolic syndrome and barrier dysfunction in Batf3-/- mice might have on susceptibility to DSS colitis, we administered an HFD to WT and Batf3-/- mice from 8 to 16 weeks of age followed by 7 days of DSS drinking water (Figures S5A).